However, there is no available information in the literature regarding the prevalence of vitamin D deficiency among patients with diffuse parenchymal lung disease or whether reduced levels are ...

Children diagnosed with interstitial lung disease often survive into adulthood, when they are likely to need care for related impairments.

Nerandomilast is under clinical development by Boehringer Ingelheim International and currently in Phase III for Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease). According to GlobalData, ...

Background Interstitial lung disease (ILD) includes a heterogeneous group of disorders that result in diffuse parenchymal lung disease, with overlapping clinical, radiographic, and physiologic ...

Various forms of diffuse parenchymal lung disease have been proposed as potential consequences of severe COVID‑19. We describe the clinical, radiological and histological findings of patients with ...

diffuse lung disease, 2) focal lung lesions 3) and systemic inflammatory responses and hypersensitivity (Table 1). Helminths that cause lung disease typically have either a larval migratory phase ...

Furthermore, the patchy nature of the lung pathology is influenced by specific disease-related alterations ... may be affected even more than the parenchyma. Emphysema is patchy at the same ...

The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

Artificial Intelligence (AI) could become a radiologist's best friend, with researchers training the technology to accurately diagnose pneumonia, COVID-19 and other lung diseases. The new study by ...